Chromatography

Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors

Retrieved on: 
Monday, March 20, 2023
Research, Technology, Medical Devices, Health Technology, Software, Biotechnology, Hardware, Pharmaceutical, Health, Science, WAT, Maintenance, Waters, QC, Econnect, Risk management, Chromatography, Multimedia, Plasma protein binding, NFC, Monolithic HPLC column, Patient, Laboratory, System, Waters Corporation, Safety, NYSE, HPLC, Medical device, Instrumentation, Airline

View the full release here: https://www.businesswire.com/news/home/20230320005167/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230320005167/en/
    The new Waters Alliance iS HPLC System is an intuitively simple, rugged, and reliable high performance liquid chromatograph designed specifically for the pharmaceutical quality control (QC) laboratory.
  • The instrument makes QC laboratories more efficient by reducing common errors that cause up to 40% of failed sample sets and subsequent out-of-specification results, re-tests and investigations.
  • The system also integrates with the cloud-native waters_connect™ System Monitoring Software enabling real-time monitoring of the Alliance iS HPLC System and any other chromatography instruments controlled by Empower Software.
  • The Waters Alliance iS HPLC System will be available starting in May 2023.

Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards

Retrieved on: 
Thursday, March 16, 2023
SEAT, Drug development, International Fertilizer Development Center, Education, Chromatography, Government, ABEA, Avantor, Biotechnology, Acceleration, Fine chemical

Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumables

Key Points: 
  • Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumables
    Singapore, Mar 16, 2023 - (ACN Newswire) - Avantor, a leading global provider of mission-critical products and services to customers in the life sciences, education, government and advanced technologies & applied materials industries, has been accorded the Best Bioprocessing Company for Chromatography at the Asia-Pacific Bioprocessing Excellence Awards 2023 (ABEA).
  • With over four decades of experience in bioprocessing, Avantor is committed to addressing the complex challenges of downstream chromatography by providing a comprehensive range of equipment, products and services.
  • "Chromatography is one of the most important components in enabling scientific breakthroughs and bringing promising biologics to market effectively.
  • "We are exceptionally proud to have been selected by the panel of industry experts and honored at this year's ceremony as the Best Bioprocessing Company - Chromatography.

RoosterBio and Repligen Collaborate to Advance Scalable Exosome Bioprocessing

Retrieved on: 
Monday, March 13, 2023
Repligen Corporation Award in Chemistry of Biological Processes, CGMP, Exosome, Health, Gene, Cell engineering, Repligen, Chromatography, TFF, Pharmaceutical industry, Fine chemical

FREDERICK, Md., March 13, 2023 /PRNewswire-PRWeb/ -- RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, development services, cell engineering, and advanced therapy bioprocess solutions, today announced that it has selected Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, as a collaboration partner to advance scalable exosome bioprocessing.

Key Points: 
  • FREDERICK, Md., March 13, 2023 /PRNewswire-PRWeb/ -- RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, development services, cell engineering, and advanced therapy bioprocess solutions, today announced that it has selected Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, as a collaboration partner to advance scalable exosome bioprocessing.
  • RoosterBio's goal, in collaboration with Repligen, is to deliver solutions for manufacturing of exosomes using scalable and low shear technologies that enable cost-effective commercialization of these advanced therapies.
  • Repligen also brings to the collaboration the ability to develop exosome affinity resins for product purification.
  • We believe that this joint collaborative effort will provide commercially and clinically viable scalable solutions for exosome manufacturing," said Vikas Gupta, VP & GM, Downstream Bioprocessing and Gene Therapy of Repligen.

Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization

Retrieved on: 
Monday, March 6, 2023
Health Technology, Data Management, Other Health, Technology, Pharmaceutical, Oncology, Biometrics, Medical Devices, Genetics, Science, Biotechnology, Software, Other Science, Health, Research, Peptide, DDA, Proteomics, Mass, Bruker, Mass spectrometry, DIA, WEHI, Acquisition, Monash University, PCA, Workflow, US, SCP, Algorithm, Machine learning, Chromatography, International, Data analysis, HT, Disease, Multimedia, BRKR, GPU, Flex, TIMS, Mobile phone, Online shopping, Fine chemical, Pharmaceutical industry, Informatics

With PaSER Novor, Bruker launches advanced capabilities for immunopeptidomics, developed in collaboration with Rapid Novor Inc., a Canadian software and CRO services company for antibody sequencing.

Key Points: 
  • With PaSER Novor, Bruker launches advanced capabilities for immunopeptidomics, developed in collaboration with Rapid Novor Inc., a Canadian software and CRO services company for antibody sequencing.
  • Immunopeptidomics requires the sequencing of peptides that are not proteolytic in nature from small tumor biopsy samples on the timsTOF SCP ultra-high sensitivity platform.
  • Co-founder and CEO of Mass Dynamics Paula Burton stated: “The integration of PaSER’s real-time search and Mass Dynamics’ discovery service is a formidable alliance.
  • The Biognosys Spectronaut® 17 software, with its novel Direct DIA+ capability, launched at the International HUPO Cancun meeting, and also fully supports dia-PASEF timsTOF data.

Chromatography Resins Global Market Report 2022: Sector to Reach $3.1 Billion by 2027 at a CAGR of 6.71% - ResearchAndMarkets.com

Retrieved on: 
Friday, March 3, 2023
Chemicals, Plastics, Health, Manufacturing, Biometrics, Chromatography, Ion exchange, F&B, Prevalence, Drink, COVID-19, Food, Interferon, Tuberculosis, Insulin, Coronavirus, Cancer, Vaccine, DNA, Tissue plasminogen activator, Fine chemical

These insights are included in the report as a major market contributor.

Key Points: 
  • These insights are included in the report as a major market contributor.
  • Chromatography resins provide support to polysaccharide beads that are packed into a column.
  • The publisher provides an analysis of the key trends in each sub-segment of the global chromatography resins market report, along with forecasts at the global, regional and country level from 2022-2027.
  • Our report has categorized the market based on product, technique and end use.

US proteomics sector set for shake-up as new IonOpticks tech unveiled

Retrieved on: 
Friday, March 3, 2023
Aurora, Proteomics, Chromatography, Heat, Thermo Fisher Scientific, SCIEX, Publication, SX, Research, Thermo, TS, Conference, Video game

MELBOURNE, Australia, March 3, 2023 /PRNewswire/ -- IonOpticks, a producer of high-performance chromatography solutions for the global research community, will introduce the new TS product range to the US market at US HUPO's (US Human Proteome Organization) 19th Annual Conference in Chicago on 4-8th March, a renowned event attended by proteomics experts from around the globe.

Key Points: 
  • "Researchers can now easily unlock the full potential of their mass specs through the launch of our new TS range.
  • Further, the heating solution in the TS is reusable which saves users both time and money while reducing unnecessary waste.
  • IonOpticks is committed to ensuring the world's best chromatography is available to all mass spec users.
  • Alongside the TS, IonOpticks have also launched the SX, a fully integrated column heating and interface solution for SCIEX users.

Genedata Screener 20 Further Accelerates and Digitalizes Assay Data Workflows -- To Be Showcased at SLAS2023

Retrieved on: 
Tuesday, February 21, 2023
Organization, Metadata, Chromatography, ROI, ChromeOS, Investment, Mass spectrometry, Data analysis, Catalog, Covalent bond, Research, San Diego Convention Center, FAIR, Selected reaction monitoring, DMTA, AstraZeneca, Drug discovery, Publishing, Fine chemical, Genedata

BASEL, Switzerland, Feb. 21, 2023 /PRNewswire-PRWeb/ -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Screener® 20. The most comprehensive digital platform for assay analysis in Biopharma R&D, Genedata Screener shortens design-make-test-analyze (DMTA) cycles in R&D through real-time data capture and automated analysis of simple and complex assays. It consolidates and FAIRifies assay information across the enterprise, including with CROs and other external collaborators. Genedata Screener provides easy access to fully integrated, up-to-date assay information to global R&D teams, providing significant time savings, and enabling efficient decision-making.

Key Points: 
  • The new Genedata Screener 20 will be featured among SLAS2023 Tutorial Sessions and demonstrated at SLAS Booth #1044 (February 25 – March 1; San Diego Convention Center).
  • Genedata Screener tremendously increases the ROI of those investments by automating the corresponding data workflows," noted Othmar Pfannes, Ph.D., CEO of Genedata.
  • "Genedata Screener intelligently captures and integrates experimental data directly from a variety of analytical instruments, ensuring that only data of the highest quality enters the automated data analysis workflows.
  • Genedata Screener digitalizes assay workflows and integrates and condenses complex experimental data to power efficient project decisions.

Viral Clearance and Viral Testing Services Global Market Report 2023: Streamlined Manufacturing and On-Time Delivery of Biologics Bolsters Adoption - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 16, 2023
Infectious Diseases, Health, Medical Devices, DNA, Organization, Biotechnology, Charles River Laboratories, Hormone, AAV, Vaccine, Patent, Prion, Sigma-Aldrich, Blood, Virus, Investment, Biocon, Safety, CPC, WuXi Biologics, RNA, Chromatography, Food, Research, Eurofins Scientific, Lentivirus, Antibody, Partnership, FDA, Growth, Filtration, A-DNA, TSE, Food and Drug Administration, COVID-19, Overalls, Creative Biolabs, GMP, Fine chemical, Marketing

A general overview of the viral clearance and testing studies, highlighting details on viral contamination in biologics and the need for viral clearance and testing.

Key Points: 
  • A general overview of the viral clearance and testing studies, highlighting details on viral contamination in biologics and the need for viral clearance and testing.
  • Answer: Presently, more than 30 companies offer various services related to viral clearance and testing, including viral testing services (such as cell bank testing, raw material testing, unprocessed bulk testing and end of production process testing) and viral clearance services (such as several virus inactivation and removal methods).
  • Question 6: What are the recent developments in the viral clearance and viral testing services market?
  • Question 7: Which geographical segment has the highest growth rate in viral clearance and viral testing services market?

Newomics Inc. Places Its 100th Mass Spectrometry Front-end System

Retrieved on: 
Wednesday, February 1, 2023
Research, Technology, Health Technology, Nanotechnology, Biotechnology, Hardware, Pharmaceutical, Health, Science, Other Science, M3, Mass spectrometry, Chromatography, MEA, Journal, Silicon, Proteomics, Analytical chemistry

Berkeley-based precision medicine solutions provider Newomics Inc. has announced the commercial placement of its 100th mass spectrometry front-end system, which has contributed to successful customer applications in the development of biotherapeutics such as Covid-19 antibodies and gene therapy, blood-based clinical diagnosis, and proteomics research.

Key Points: 
  • Berkeley-based precision medicine solutions provider Newomics Inc. has announced the commercial placement of its 100th mass spectrometry front-end system, which has contributed to successful customer applications in the development of biotherapeutics such as Covid-19 antibodies and gene therapy, blood-based clinical diagnosis, and proteomics research.
  • The system is made up of an ion source integrated with breakthrough silicon microfluidic chips including M3 emitters and MEA chips.
  • System models include the MnESI system with M3 emitters launched in November 2020, and the DuoESI system with M3 emitters and MEA chips launched in June 2022.
  • We will continue to fulfill customer needs and address the challenges in their mass spectrometry workflows in 2023 and beyond.”

New waters_connect System Monitoring Software Maximizes Productivity with Real-Time, Cloud-Native Lab Management

Retrieved on: 
Wednesday, January 25, 2023
Data Management, Apps, Applications, Technology, Manufacturing, Software, Other Manufacturing, Software as a service, Chromatography, WAT, QA/QC, Multimedia, NYSE, Waters Corporation, Pharmacy, Monitor lizard, Patient

View the full release here: https://www.businesswire.com/news/home/20230125005060/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230125005060/en/
    The waters_connect System Monitoring app is the only cloud-native software application that enables real-time monitoring of all chromatography instruments controlled by Waters Empower software.
  • (Photo: Business Wire)
    The waters_connect System Monitoring application was developed especially for high-volume quality assurance/quality control (QA/QC) laboratories.
  • The cloud-native application also helps lab managers utilize capital resources better by providing an understanding of instrument history and usage levels and improve the productivity of their teams.
  • “The ‘always-on’ waters_connect System Monitoring dashboard lets lab managers and analysts look in on their instrument fleet from anywhere, anytime and helps them improve product release timelines and delivery schedules.”
    The waters_connect System Monitoring application is available immediately in Europe and North America.